The development of the treatment of autoimmune diseases by cytokine gene transfer
细胞因子基因转移治疗自身免疫性疾病的研究进展
基本信息
- 批准号:07457122
- 负责人:
- 金额:$ 4.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1) Establishment of myelin basic protein (MBP)-specific T cell lines ;Lymph node cells were obtained from Lewis rats immunized with MBP peptide (68-88) and cultured with a repetitive stimulation with MBP and interleukin 2. T cell lines thus obtained were transfered to naive syngeneic rats and the induction of encephalomyelitis (experimental allergic encephalomyelitis ; EAE) was confirmed.(2) Transfer of cytokine genes to T cell lines ;Expression vectors for cytokine genes (IL-4, IL-10, TGFbeta) were prepared and transfected into COS cells. The culture supernatants were confirmed to have corresponding cytokine activities and those from TGFbeta-transfected COS cells strongly inhibited the proliferation of MBP-stimulated T cell lines in vitro. These cell lines were transferred into Lewis rats immunized with MBP peptide to examine whether cytokine-gene transfer successfully inhibit the induction of EAE.
(1)髓鞘碱性蛋白(MBP)特异性T细胞系的建立:从用MBP肽(68-88)免疫的刘易斯大鼠获得淋巴结细胞,并用MBP和白细胞介素2重复刺激培养。将由此获得的T细胞系转移到幼稚的同基因大鼠中,证实了脑脊髓炎(实验性变态反应性脑脊髓炎; EAE)的诱导。(2)将细胞因子基因转移至T细胞系;制备细胞因子基因(IL-4、IL-10、TGF β)的表达载体并转染至COS细胞中。结果表明,转染TGF β的COS细胞培养上清具有相应的细胞因子活性,并能显著抑制MBP刺激的T细胞系的增殖。将这些细胞系转移到用MBP肽免疫的刘易斯大鼠中,以检查是否成功地抑制了EAE的诱导。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mizushima N,et al.: "Ceramide induced apoptosis via CPP32 activation." FEBS Letters. 395. 267-271 (1996)
Mizushima N 等人:“神经酰胺通过 CPP32 激活诱导细胞凋亡。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIYASAKA Nobuyuki其他文献
MIYASAKA Nobuyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIYASAKA Nobuyuki', 18)}}的其他基金
Clinical Application of Cell Cycle Control Therapy to Rheumatoid Arthritis
细胞周期调控疗法在类风湿性关节炎中的临床应用
- 批准号:
13854014 - 财政年份:2001
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
The role of MAdCAM-1 for induction and maintenance of oral tolerance -analysis with animal model of arthritis
MAdCAM-1 在诱导和维持口服耐受中的作用 - 关节炎动物模型分析
- 批准号:
11557037 - 财政年份:1999
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cell Cycle Control for Treatment of Rheumatoid Arthritis
细胞周期控制治疗类风湿关节炎
- 批准号:
10470124 - 财政年份:1998
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Gene cloning of a novel cytokine inducing ICAM-1
诱导 ICAM-1 的新型细胞因子的基因克隆
- 批准号:
04670382 - 财政年份:1992
- 资助金额:
$ 4.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Functional consequences of intergenic autoimmune disease risk variants
基因间自身免疫性疾病风险变异的功能后果
- 批准号:
10655161 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
PTSD and Autoimmune Disease: Towards Causal Effects, Risk Factors, and Mitigators
创伤后应激障碍 (PTSD) 和自身免疫性疾病:因果效应、危险因素和缓解措施
- 批准号:
10696671 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Build to LEAD – Building partnerships to Link the Exposome to Autoimmune Disease
构建引领 — 建立合作伙伴关系,将暴露组与自身免疫性疾病联系起来
- 批准号:
10871040 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Development of a novel class of ion channel blockers for the treatment of autoimmune disease
开发一类新型离子通道阻滞剂用于治疗自身免疫性疾病
- 批准号:
10053003 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Collaborative R&D
Enhancing the IMHRD cohort to support study of the exposome in autoimmune disease
加强 IMHRD 队列以支持自身免疫性疾病暴露组研究
- 批准号:
10871488 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Treating pain in autoimmune disease: concurrent use of opioids and biologic medication
治疗自身免疫性疾病的疼痛:同时使用阿片类药物和生物药物
- 批准号:
10607303 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Innate Immune Mediated Changes in Renal Function to Cause Hypertension in Females with Autoimmune Disease
先天免疫介导的肾功能变化导致患有自身免疫性疾病的女性高血压
- 批准号:
10714533 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:
Novel approaches for the treatment of autoimmune disease
治疗自身免疫性疾病的新方法
- 批准号:
10601899 - 财政年份:2023
- 资助金额:
$ 4.54万 - 项目类别:














{{item.name}}会员




